The legacy of the blue pill offers a complicated case study for investors eyeing pharma. While initial sales were remarkable, recent patent expiration and the emergence of generic versions have severely influenced https://jimrvho463690.elbloglibre.com/41397683/sildenafil-and-pharma-a-risky-investment